GLP-1 medication access online for Shreveport, Louisiana
Company statements checked September 10, 2026: 1 covered company — Gentle Health — advertises online GLP-1 medication access for patients in Louisiana, including Shreveport. Confirm eligibility and total charges with the provider.
Browse online GLP-1 medication access programs advertised for patients in Shreveport, Louisiana, with state-level access evidence.
Inside Telehealth Editorial · Updated
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| Gentle Health | Compounded oral semaglutide · Compounded injectable semaglutide · Compounded injectable tirzepatide | $112/mo advertised monthly bundle, Compounded oral semaglutide | Official site ↗ |
Health context in Shreveport
GLP-1 medication access programs are marketed for weight management and, for some products, type 2 diabetes. These Shreveport figures give local context only. Among the 5 Louisiana cities in this research set, Shreveport has the highest estimate for obesity among adults (43.4%), the tied for highest estimate for high blood pressure among adults (43.5%), the highest estimate for lack of health insurance among adults aged 18–64 (9.9%) and the highest estimate for routine checkup in the past year among adults (82.6%).
| Measure | Shreveport | 95% range | Among the 5 Louisiana cities in this research set | Year |
|---|---|---|---|---|
| Obesity among adults | 43.4% | 37.9–48.3% | highest | 2023 |
| Diagnosed diabetes among adults | 15.6% | 13.8–17.3% | second-highest | 2023 |
| High blood pressure among adults | 43.5% | 39.8–46.9% | tied for highest | 2023 |
| Lack of health insurance among adults aged 18–64 | 9.9% | 8.6–11.2% | highest | 2023 |
| Routine checkup in the past year among adults | 82.6% | 79.6–85.1% | highest | 2023 |
Source: CDC PLACES, 2025 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 187,593); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.
For Shreveport readers, Gentle Health’s Louisiana statewide online GLP-1 listing includes compounded oral semaglutide, injectable semaglutide and injectable tirzepatide. The company’s process for Louisiana starts with a scheduled video evaluation after intake.
The state guide explains that first-visit step and the separately priced programs. Online intake does not complete the video visit or ensure a prescription; confirm the appointment process before moving on to shipment and payment questions.
These are online services advertised for patients in Louisiana, listed alphabetically. They are not verified offices, pharmacies or clinicians located in Shreveport, and a listing is not a prescription, appointment or coverage guarantee. Read the Louisiana GLP-1 medication access guide for product details, charges and limitations.
Selected providers
Gentle Health
Gentle Health's separately priced compounded oral semaglutide, injectable semaglutide and injectable tirzepatide programs, if prescribed.
Compounded oral semaglutide (oral): 2–4 mg/day — $112/mo · >4–8 mg/day — $189/mo · >8–12 mg/day — $258/mo
Compounded injectable semaglutide (injection): 0.24–0.48 mg/wk — $135/mo · >0.48–1.2 mg/wk — $159/mo · >1.2–2.4 mg/wk — $199/mo
Compounded injectable tirzepatide (injection): 2.5–5 mg/wk — $169/mo · >5–10 mg/wk — $219/mo · >10–15 mg/wk — $269/mo
- Compounded oral semaglutide — oral: state evidence checked · Availability source · Full evidence notes
- Compounded injectable semaglutide — injection: state evidence checked · Availability source · Full evidence notes
- Compounded injectable tirzepatide — injection: state evidence checked · Availability source · Full evidence notes
Official provider website · Product and access details
Medical Director: James Simmons, MD — company-reported; see profile for the source.
Health center sites with Shreveport addresses
If you want an in-person visit, HRSA-listed health center sites with Shreveport postal addresses include:
- CASSE-Shreveport Pediatrics, OB/GYN, Dentistry, and Behavioral Health (Council for The Advancement of Social Services and Education) — 2120 Bert Kouns Industrial Loop, Suite A, Shreveport, LA 71118 · 318-688-3350
- David Raines Community Health Center (David Raines Community Health Center Inc) — 3021 W 70th St, Shreveport, LA 71108 · 318-227-3350
From the HRSA health center directory (data retrieved ), listed alphabetically by organization and matched by postal address, not city boundaries; the list includes health center look-alikes, which do not receive Health Center Program funding. Not a ranking or recommendation. Call to confirm services, costs and whether a site can help with the programs on this page.
More listings
Other medications for Shreveport: Semaglutide · Tirzepatide
GLP-1 medication access in other Louisiana cities: Baton Rouge · Lafayette · Metairie · New Orleans
Before requesting a prescription
Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.